IPOs this week : October 26 - 30, 20 (wk 44)

 IPOs expected to price

• Amerihome (AHM) on October 28. The offering of 14.7M shares is expected to price in a range of $16 to $18. 
• Biodesix (BDSX) also slated to price its IPO on October 28, with 4.17M shares due to go off in an expected range of $17 to $19. 
• Allegro MicroSystems (ALGM), Caliber Home Loans (HOMS), Leslie's (LESL), Root (ROOT) and Mavenir (MVNR). 

IPO quiet period expirations

• Keep an eye on avocado pure-play Mission Produce (NASDAQ:AVO) with the analyst quiet period expiring following the company's IPO. Shares have shown a modest gain from the IPO pricing level of $12. 

IPO lockup expirations

• IPO lockups expire on Sprout Social (NASDAQ:SPT), Lyra Therapeutics (NASDAQ:LYRA) and Zentalis Pharmaceuticals (NASDAQ:ZNTL). 

Ant Group has secured the final regulatory approval to launch what is shaping up to be the world's largest initial public offering. The Mainland China leg of the IPO will be priced on October 27. Ant has been running a digital IPO roadshow across Asia, Europe and the U.S. to gauge investor interest.

Lyra Therapeutics (LYRA) began trading on the Nasdaq on Mon 4 May 2020

Lyra Therapeutics (LYRA) has priced its IPO of 3.5M common shares at $16/share, yielding gross proceeds of $56M.

Underwriters' over-allotment is an additional 525,000 shares.

https://lyratherapeutics.com/

The company is advancing two drug candidates for the treatment of chronic rhinosinusitis.

LYRA has produced very promising trial results and the IPO appears reasonably valued, so for life science investors with a 12 - 18-month hold time frame, the IPO looks quite interesting.

Company & Technology

Watertown, Massachusetts-based Lyra was founded to develop drug treatments for two types of patients with chronic rhinosinusitis, those who are 'surgically-naive' and those who have been previously operated on for the condition.

Management is headed by Maria Palasis, Ph.D., who has been with the firm since 2011 and was previously EVP at Arsenal Medical.

A brief overview video of chronic rhinosinusitis: